Hedwig E. Deubzer

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (6)

Jörg Fallmann

Leipzig University

GERMANY

View details

Michael Hubank

University College London

UNITED KINGDOM

View details

Angelika Eggert

Full Professor of Pediatrics & Director

Charité - Universitätsmedizin Berlin

GERMANY

View details

Michael Boettcher

Juniorprofessor

Martin Luther University Halle-Wittenberg

GERMANY

View details

Johannes Hubertus Schulte

Head of Pediatric Stem Cell Transplantation; Professor of Pediatric Oncology Research

Charité Universitätsmedizin Berlin - Campus Virchow-Klinikum

GERMANY

View details

Michael Launspach

Charité

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hedwig E. Deubzer

Research Interests

Explore related searches

Contact this professor

Articles (11)

Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B-cell impairment and increases the risk for infections - a retrospective matched cohort study.

Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN.

Treatment of Infants and Children With SARS-CoV-2 Monoclonal Antibodies: A European Case Series.

Circulating Cell-Free DNA Assessment in Biofluids from Children with Neuroblastoma Demonstrates Feasibility and Potential for Minimally Invasive Molecular Diagnostics

Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells.

Efficacy and Feasibility of Proton Beam Therapy in Relapsed High-Risk Neuroblastoma-Experiences from the Prospective KiProReg Registry

Genomic Evolution and Personalized Therapy of an Infantile Fibrosarcoma Harboring an<i>NTRK</i>Oncogenic Fusion

A Deep Dive into the Circulating ctDNA Cosmos to Vanquish Neuroblastoma

Evidence of neural crest cell origin of a DICER1 mutant CNS sarcoma in a child with DICER1 syndrome and NRAS-mutant neurocutaneous melanosis.

Genomic Evolution and Personalized Therapy of an Infantile Fibrosarcoma Harboring an NTRK Oncogenic Fusion.

Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL - long-term follow-up from the prospective ALL-SCT 2003 trial.

Collaborators (6)

Jörg Fallmann

Michael Hubank

Angelika Eggert

Michael Boettcher

Johannes Hubertus Schulte

Michael Launspach

Make your next move.